Comparing the efficacy of Intravenous Paracetamol to Imtramuscular Pethidine for labour analgesia in ILorin: A randomized controlled study.

Not Applicable

• Conditions: Pregnancy and Childbirth; Labour pain Relief

• Registration Number: PACTR202308755450519
• Lead Sponsor: Self funded

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-07-24
• Last Update Posted: 4 March 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 96

Inclusion Criteria

INCLUSION CRITERIA
Women with term gestation (37 to 42 weeks), with singleton fetus in cephalic presentation
Women who present in active phase of labour (cervical dilatation of 4-6cm), either spontaneous or induced
Consent to participate in the study.

Exclusion Criteria

EXCLUSION CRITERIA
Women with cervical dilatation of 7cm or more.
Multiple gestation.
Women with previous uterine surgery (caesarean section, myomectomy).
Women with antepartum haemorrhage in index pregnancy.
History of hyper-sensitivity to PCM and/or pethidine.
Women with diagnosed liver disease and / or sickle cell disease patient.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Maternal labour pain score perception and satisfaction level with pain relief. Measured with VAS and Likert scale respectively <br>

Secondary Outcome Measures

Name	Time	Method
Maternal side effects (Nausea, vomiting, drowsiness, dyspnoea and hypotension) <br>2. Fetal heart rate abnormalities.<br>3. Duration of labour (drug –delivery interval)<br>4. Apgar score less than seven at five minutes and need for NICU admission<br>5. Need for anti-opioid (Naloxone).